GWAS
Omecu, a spinout from the University of Edinburgh, has developed a proprietary computation engine to analyze large datasets like the UK Biobank.
Myasthenia Gravis Study Identifies Genetic Risk Loci Affecting Acetylcholine Receptor
Combining a genome-wide and a transcriptome-wide association study, the work also implicated different loci in early-onset and late-onset versions of the disease.
New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions
Combining eQTL and GWAS results, researchers at the Icahn School of Medicine at Mount Sinai detected hundreds of candidate causal variants for various brain traits.
23andMe Study Associates Gene Locus With COVID-19-Related Loss of Smell, Taste
A multi-ancestry genome-wide association study found that genetics likely contributes to the loss of smell or taste in COVID-19 patients.
GWAS With Higher Genetic Diversity Lead to More Accurate Use of Polygenic Risk Scores
Increasing diversity in large studies results in substantial improvements in fine-mapping functional variants and portability of polygenic prediction.